Výsledky vyhledávání - Francesco Tovoli
- Zobrazuji výsledky 1 - 20 z 27
- Přejít na další stránku
-
1
-
2
-
3
-
4
-
5
Clinical and diagnostic aspects of gluten related disorders Autor Francesco Tovoli, C Masi, Elena Guidetti, Giulia Negrini, Paola Paterini, Luigi Bolondi
Vydáno 2015Revisão -
6
-
7
Increased risk of nonalcoholic fatty liver disease in patients with coeliac disease on a gluten‐free diet: beyond traditional metabolic factors Autor Francesco Tovoli, Giulia Negrini, Roberto Farì, Elena Guidetti, Chiara Faggiano, Lucia Napoli, Luigi Bolondi, Alessandro Granito
Vydáno 2018Artigo -
8
-
9
-
10
-
11
The Feasibility of Liver Biopsy for Undefined Nodules in Patients under Surveillance for Hepatocellular Carcinoma: Is Biopsy Really a Useful Tool? Autor Matteo Renzulli, Anna Pecorelli, Nicolò Brandi, Stefano Brocchi, Francesco Tovoli, Alessandro Granito, Gianpaolo Carrafiello, Anna Maria Ierardi, Rita Golfieri
Vydáno 2022Artigo -
12
Imaging of Colorectal Liver Metastases: New Developments and Pending Issues Autor Matteo Renzulli, Alfredo Clemente, Anna Maria Ierardi, Irene Pettinari, Francesco Tovoli, Stefano Brocchi, Giuliano Peta, Salvatore Cappabianca, Gianpaolo Carrafiello, Rita Golfieri
Vydáno 2020Revisão -
13
Metronomic capecitabine vs. best supportive care in Child-Pugh B hepatocellular carcinoma: a proof of concept Autor Stefania De Lorenzo, Francesco Tovoli, Maria Aurelia Barbera, Francesca Garuti, Andrea Palloni, Giorgio Frega, Ingrid Garajová, Alessandro Rizzo, Franco Trevisani, Giovanni Brandi
Vydáno 2018Artigo -
14
Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patients Autor Francesco Tovoli, Luca Ielasi, Andrea Casadei‐Gardini, Alessandro Granito, Francesco Giuseppe Foschi, Giulia Rovesti, Giulia Negrini, Giulia Orsi, Matteo Renzulli, Fabio Piscaglia
Vydáno 2019Artigo -
15
Early CTLA4 increase in CD45+ blood cells: an emerging biomarker of atezolizumab–bevacizumab resistance and worse survival in advanced hepatocarcinoma Autor L. Gramantieri, Annapaola Montagner, Andrea Arleo, F. Suzzi, Cristian Bassi, Francesco Tovoli, Mariangela Bruccoleri, Eleonora Alimenti, Francesca Fornari, Massimo Iavarone, M. Negrini, Fabio Piscaglia, Catia Giovannini
Vydáno 2025Artigo -
16
TRANS-TACE: Prognostic Role of the Transient Hypertransaminasemia after Conventional Chemoembolization for Hepatocellular Carcinoma Autor Alessandro Granito, Antonio Facciorusso, Rodolfo Sacco, Laura Bartalena, Cristina Mosconi, Ugo Vittorio, Alberta Cappelli, Matteo Antonino, Francesco Modestino, Nicolò Brandi, Francesco Tovoli, Fabio Piscaglia, Rita Golfieri, Matteo Renzulli
Vydáno 2021Artigo -
17
Non-Alcoholic Steatohepatitis as a Risk Factor for Intrahepatic Cholangiocarcinoma and Its Prognostic Role Autor Stefania De Lorenzo, Francesco Tovoli, Alessandro Mazzotta, Francesco Vasuri, Julien Edeline, Deborah Malvi, Karim Boudjéma, Matteo Renzulli, Heithem Jeddou, Antonietta D’Errico, Bruno Turlin, Matteo Cescon, Thomas Uguen, Alessandro Granito, Astrid Lièvre, Giovanni Brandi
Vydáno 2020Artigo -
18
Liver decompensation in patients with hepatocellular carcinoma treated with Atezolizumab plus Bevacizumab: a real-life study Autor Leonardo Stella, Maria Pallozzi, Lucia Cerrito, Francesco Santopaolo, Francesco Tovoli, Clémence Hollande, Sabrina Sidali, Bernardo Stefanini, Claudia Campani, Elisa Pellegrini, Giuseppe Cabibbo, Fabio Marra, Fabio Piscaglia, Antonio Gasbarrini, Maurizio Pompili, Mohamed Bouattour, Francesca Romana Ponziani
Vydáno 2025Artigo -
19
Benefits, Open questions and Challenges of the use of Ultrasound in the COVID-19 pandemic era. The views of a panel of worldwide international experts Autor Fabio Piscaglia, Federico Stefanini, Vito Cantisani, Paul S. Sidhu, R. Graham Barr, Annalisa Berzigotti, Maria Cristina Chammas, Jean-Michel Correas, Christoph F. Dietrich, Steven B. Feinstein, Pintong Huang, Christian Jenssen, Yuko Kono, Masatoshi Kudo, Ping Liang, Andrej Lyshchik, Christian Nolsøe, Xyaoyan Xie, Francesco Tovoli
Vydáno 2020Artigo -
20
Overall survival and objective response in advanced unresectable hepatocellular carcinoma: A subanalysis of the REFLECT study Autor Masatoshi Kudo, Richard S. Finn, Shukui Qin, Kwang‐Hyub Han, Kenji Ikeda, Ann‐Lii Cheng, Arndt Vogel, Francesco Tovoli, Kazuomi Ueshima, Hiroshi Aikata, Carlos López, Marc Pracht, Zhiqiang Meng, Bruno Daniele, Joong‐Won Park, D. Palmer, Toshiyuki Tamai, Kenichi Saito, Corina E. Dutcus, Riccardo Lencioni
Vydáno 2022Artigo
Vyhledávací nástroje:
Související témata
Medicine
Internal medicine
Hepatocellular carcinoma
Gastroenterology
Oncology
Cancer
Disease
Sorafenib
Immunology
Immunotherapy
Pathology
Adverse effect
Environmental health
Nivolumab
Surgery
Biology
Cancer research
Chemotherapy
Confidence interval
Fatty liver
Population
Atezolizumab
Bevacizumab
Family medicine
Gluten
Lenvatinib
Multivariate analysis
Antibody
Biochemistry
Carcinoma